Clinical studies of multiple endocrine neoplasia type 1 (MEN1)

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by the combined occurrence of parathyroid, pancreatic islet and anterior pituitary tumours. To facilitate a screening programme for MEN1, we investigated 709 people (364 males and 345 females, age range 1-84 years) from 62 MEN1 families, and 36 non-familial MEN1 patients. Of those investigated, 220 (95 males and 125 females, age range 8-79 years) suffered from MEN1. Parathyroid, pancreatic and pituitary tumours occurred in 95%, 41% and 30% of the patients, respectively. Parathyroid tumours were the first manifestation of MEN1 in 87% of patients, and amongst the pituitary and pancreatic tumours, somatotrophinomas and gastrinomas were more common in patients above the age of 40 years, whilst insulinomas occurred more frequently in patients below the age of 40 years. Biochemical screening indicated that the penetrance of MEN1 by the ages of 20, 35 and 50 years was 43%, 85% and 94%, respectively, and that the development of MEN1 was confined to first-degree relatives in 91% of patients and to second-degree relatives in 9% of patients. These findings have helped to define a proposed screening programme for MEN1.

[1]  P. Chanson,et al.  Multiple endocrine neoplasia type 1 in France: clinical and genetic studies , 1995, Journal of internal medicine.

[2]  J. Webster,et al.  A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea , 1994, The New England journal of medicine.

[3]  D. O’Halloran,et al.  A family pedigree exhibiting features of both multiple endocrine neoplasia type 1 and McCune-Albright syndromes. , 1994, The Journal of clinical endocrinology and metabolism.

[4]  R. Thakker The role of molecular genetics in screening for multiple endocrine neoplasia type 1. , 1994, Endocrinology and metabolism clinics of North America.

[5]  J. Rastad,et al.  Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. , 1992, The Journal of clinical endocrinology and metabolism.

[6]  J. Rastad,et al.  Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. , 1991, The Journal of clinical endocrinology and metabolism.

[7]  S. Marx ???Familial Multiple Endocrine Adenoma???Peptic Ulcer Complex???: A Classic in Medicine , 1991 .

[8]  P. Bouloux,et al.  Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. , 1989, The New England journal of medicine.

[9]  C. Larsson,et al.  Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma , 1988, Nature.

[10]  G. Åkerström,et al.  Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1. , 1987, The American journal of medicine.

[11]  A. Vinik,et al.  Multiple Endocrine Neoplasia Type I: Assessment of Laboratory Tests to Screen for the Gene in a Large Kindred , 1986, Medicine.

[12]  R. Thakker,et al.  Circulating concentrations of 1,25-dihydroxyvitamin D3 in patients with primary hyperparathyroidism. , 1986, Bone and Mineral.

[13]  R. Lasker,et al.  Familial hypocalciuric hypercalcemia. The relation to primary parathyroid hyperplasia , 1982 .

[14]  S. D. Wilson,et al.  The MEA-I syndrome: an all or none phenomenon? , 1979, Surgery.

[15]  A. Knudson,et al.  Mutation and cancer: neuroblastoma and pheochromocytoma. , 1972, American journal of human genetics.

[16]  A. Knudson,et al.  Mutation and cancer: a model for Wilms' tumor of the kidney. , 1972, Journal of the National Cancer Institute.

[17]  A. Knudson Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Hartsock,et al.  FAMILIAL MULTIPLE ENDOCRINE ADENOMA‐PEPTIC ULCER COMPLEX , 1964, Medicine.

[19]  P. Wermer Genetic aspects of adenomatosis of endocrine glands. , 1954, The American journal of medicine.